Ulrich Budde Selected Research

Septic Shock (Toxic Shock Syndrome)

12/2022	Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial.
1/2020	Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulrich Budde Research Topics

Disease

30	Hemorrhage 10/2022 - 04/2002
19	Thrombotic Thrombocytopenic Purpura 01/2021 - 07/2002
16	von Willebrand Diseases (von Willebrand's Disease) 01/2022 - 04/2002
8	Type 3 von Willebrand Disease 01/2023 - 11/2005
7	Type 1 von Willebrand Disease 01/2020 - 01/2007
5	Inflammation (Inflammations) 01/2022 - 01/2008
5	Thrombosis (Thrombus) 12/2018 - 09/2006
4	COVID-19 01/2023 - 01/2021
4	Aortic Valve Stenosis (Aortic Stenosis) 02/2019 - 12/2008
4	Thrombocytopenia (Thrombopenia) 02/2017 - 01/2004
4	Thrombotic Microangiopathies 12/2016 - 10/2002
4	Hemophilia A (Haemophilia) 03/2013 - 11/2005
3	Sepsis (Septicemia) 12/2022 - 02/2009
3	Ischemic Stroke 01/2022 - 01/2018
3	acquired Thrombotic thrombocytopenic purpura 01/2019 - 07/2008
3	Infections 02/2017 - 09/2004
3	Type 2 von Willebrand Disease 01/2013 - 06/2004
2	Hemolysis 11/2023 - 01/2014
2	Stroke (Strokes) 11/2023 - 01/2022
2	Multiple Myeloma 01/2023 - 05/2016
2	Critical Illness (Critically Ill) 01/2023 - 01/2022
2	Thromboinflammation 01/2023 - 01/2021
2	Septic Shock (Toxic Shock Syndrome) 12/2022 - 01/2020
2	Vascular System Injuries 01/2019 - 04/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2015 - 09/2004
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2014 - 09/2006
2	Monoclonal Gammopathy of Undetermined Significance 03/2011 - 09/2006
2	Hemolytic Anemia 09/2010 - 09/2004
2	Wounds and Injuries (Trauma) 11/2005 - 06/2004
2	Hemolytic-Uremic Syndrome 09/2004 - 03/2003
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2004 - 03/2003
2	Evans Syndrome 01/2004 - 03/2003
1	Sickle Cell Anemia (Hemoglobin S Disease) 11/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2023
1	Pneumonia (Pneumonitis) 01/2022
1	Disease Progression 01/2020
1	Menorrhagia 01/2020
1	Epistaxis (Nosebleed) 01/2020
1	Hemarthrosis 01/2020
1	Immunoglobulin Light-chain Amyloidosis 05/2016
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 05/2016
1	Falciparum Malaria (Plasmodium falciparum Malaria) 03/2016
1	Cerebral Malaria 03/2016
1	Atypical Hemolytic Uremic Syndrome 01/2016

Drug/Important Bio-Agent (IBA)

55	von Willebrand FactorIBA 11/2023 - 04/2002
14	thiamine triphosphorate (TTP)IBA 01/2020 - 07/2002
11	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 06/2004
10	AntigensIBA 10/2022 - 06/2004
8	Metalloproteases (Metalloproteinases)IBA 01/2022 - 07/2006
7	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 10/2022 - 06/2004
7	DisintegrinsIBA 01/2022 - 06/2010
7	ThrombospondinsIBA 01/2022 - 06/2010
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2007
5	AutoantibodiesIBA 01/2023 - 03/2011
5	Hemostatics (Antihemorrhagics)IBA 01/2020 - 04/2002
4	AntibodiesIBA 01/2023 - 01/2014
4	CollagenIBA 01/2021 - 06/2004
4	Peptide Hydrolases (Proteases)FDA Link 01/2015 - 07/2002
3	Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA 10/2020 - 02/2008
3	CoagulantsIBA 01/2020 - 06/2004
3	Glycoproteins (Glycoprotein)IBA 01/2019 - 04/2002
3	Proteins (Proteins, Gene)FDA Link 09/2017 - 11/2005
3	RistocetinIBA 01/2015 - 11/2005
3	ADAMTS13 ProteinIBA 03/2010 - 07/2002
3	von Willebrand factor drug combination factor VIIIIBA 01/2007 - 04/2002
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2022 - 01/2020
2	Epinephrine (Adrenaline)FDA LinkGeneric 10/2022 - 03/2020
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2022 - 04/2013
2	Fibrinolysin FDA Link 01/2017 - 05/2016
2	Immunoglobulin M (IgM)IBA 05/2016 - 01/2009
2	Immunoglobulin G (IgG)IBA 01/2014 - 09/2006
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2014 - 09/2010
2	Inosine Triphosphate (ITP)IBA 01/2004 - 03/2003
1	IsoantibodiesIBA 01/2023
1	Adenosine Diphosphate (ADP)IBA 10/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020
1	CreatinineIBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Thrombospondin 1IBA 12/2018
1	Thromboplastin (Tissue Factor)IBA 09/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2018
1	symmetric dimethylarginineIBA 01/2018
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Inflammation MediatorsIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2017
1	Sepharose (Agarose)IBA 05/2016
1	ParaproteinsIBA 05/2016

Therapy/Procedure

9	Therapeutics 01/2023 - 04/2011
5	Plasma Exchange 12/2022 - 10/2002
3	Heart-Assist Devices 04/2014 - 04/2008
2	Minor Surgical Procedures (Minor Surgery) 11/2005 - 06/2004
1	Blood Transfusion (Blood Transfusions) 11/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Secondary Prevention 01/2022
1	Tooth Extraction (Tooth Extractions) 01/2020
1	Ligation 01/2020
1	Plasmapheresis 05/2016